- Home
- About
- Team
- Today's Market
- Premium
- Research it
- Outlook
- Portfolio
- Mobile
- Trust Equitymaster
- Help
- Free Reports
MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- APOLLO HOSPITALS ENTERPRISE LIMITED (health services)
- Latest 8 Quarter Result
APOLLO HOSPITALS Quarterly Results 
(APLH)
Here are the latest quarterly results of APOLLO HOSPITALS. For more details, see the APOLLO HOSPITALS financial fact sheet and APOLLO HOSPITALS share price and chart.
APOLLO HOSPITALS Quarterly Results
| No. of Mths Qtr. Ending |
3
Sep-16 |
3
Dec-16 |
3
Mar-17* |
3
Jun-17 |
3
Sep-17 |
3
Dec-17 |
3
Mar-18 |
3
Jun-18 |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 16,341 | 16,806 | 16,616 | 16,845 | 18,516 | 18,961 | 18,629 | 19,104 | |
| Other income | Rs m | 94 | 31 | 91 | 38 | 26 | 79 | 58 | 21 | |
| Turnover | Rs m | 16,435 | 16,837 | 16,708 | 16,882 | 18,543 | 19,040 | 18,688 | 19,124 | |
| Expenses | Rs m | 14,122 | 14,865 | 14,916 | 15,108 | 16,304 | 16,749 | 16,493 | 16,837 | |
| Gross profit | Rs m | 2,219 | 1,941 | 1,701 | 1,661 | 2,212 | 2,213 | 2,136 | 2,267 | |
| Depreciation | Rs m | 603 | 618 | 628 | 646 | 665 | 678 | 731 | 724 | |
| Interest | Rs m | 469 | 513 | 578 | 555 | 588 | 635 | 624 | 621 | |
| Profit before tax | Rs m | 1,242 | 841 | 586 | 498 | 986 | 978 | 839 | 942 | |
| Tax | Rs m | 322 | 112 | 104 | 146 | 277 | 304 | 242 | 341 | |
| Profit after tax | Rs m | 920 | 728 | 482 | 352 | 709 | 674 | 596 | 602 | |
| Gross profit margin | % | 13.6 | 11.5 | 10.2 | 9.9 | 11.9 | 11.7 | 11.5 | 11.9 | |
| Effective tax rate | % | 25.9 | 13.4 | 17.8 | 29.3 | 28.1 | 31.1 | 28.9 | 36.2 | |
| Net profit margin | % | 5.6 | 4.3 | 2.9 | 2.1 | 3.8 | 3.6 | 3.2 | 3.1 | |
| Diluted EPS | Rs | 6.6 | 5.2 | 3.5 | 2.5 | 5.1 | 4.8 | 4.3 | 4.3 | |
| Diluted EPS (TTM) | Rs | 25.1 | 22.5 | 20.5 | 17.8 | 16.3 | 15.9 | 16.8 | 18.6 | |
 Subscriber Feature |
||||||||||
Interim results exclude extraordinary / exceptional items
Read: APOLLO HOSPITALS 1QFY19 Result Performance Review
More Health Services Company Quarterly Results: INFOMEDIA PRESS GLODYNE TECHNOSERVE CENTURY PLYBOARDS ORISSA MINERALS DEV. GOKALDAS EXPORTS
Compare APOLLO HOSPITALS With: INFOMEDIA PRESS GLODYNE TECHNOSERVE CENTURY PLYBOARDS ORISSA MINERALS DEV. GOKALDAS EXPORTS
Compare APOLLO HOSPITALS With: HP (US) IBM (US) KINGDEE INTER. (China) CHINASOFT (China)
|
| |
Today's Market
Sensex Ends 132 Points Higher; IT and Healthcare Stocks Witness Buying(Closing)
After trading on a volatile note throughout the day, share markets in India witnessed buying interest during the closing hours and ended the day in green.
Views on news
APOLLO HOSPITALS Announces Quarterly Results (1QFY19); Net Profit Up 70.9% (Quarterly Result Update)
Aug 13, 2018 | Updated on Aug 13, 2018For the quarter ended June 2018, APOLLO HOSPITALS has posted a net profit of Rs 602 m (up 70.9% YoY). Sales on the other hand came in at Rs 19 bn (up 13.4% YoY). Read on for a complete analysis of APOLLO HOSPITALS's quarterly results.
APOLLO HOSPITALS Announces Quarterly Results (4QFY18); Net Profit Up 23.8% (Quarterly Result Update)
Jun 1, 2018 | Updated on Jun 1, 2018For the quarter ended March 2018, APOLLO HOSPITALS has posted a net profit of Rs 596 m (up 23.8% YoY). Sales on the other hand came in at Rs 19 bn (up 12.1% YoY). Read on for a complete analysis of APOLLO HOSPITALS's quarterly results.
Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)
Mar 14, 2018Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?
Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)
Mar 12, 2018Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?
Apollo Micro Systems Ltd. (IPO)
Jan 9, 2018Should you subscribe to the IPO of Apollo Micro Systems Ltd?
More Views on NewsMost Popular
Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)
Oct 5, 2018Find companies with long term durable moats, which are correcting with the current broader market sell-off.
Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)
Oct 4, 2018Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.
Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)
Oct 5, 2018Ajit Dayal on the crisis in the market and in the mutual fund industry.
Why Are Investors In Sundaram Small Cap Fund Anxious(Outside View)
Oct 3, 2018A small cap fund that aims to capitalise on emerging businesses and catch them young. However, its failure in keeping volatility under check is making its investors anxious.
Biggest Corrections in the Stock of Infibeam Avenues(Chart Of The Day)
Oct 3, 2018Infibeam plunged over 70% last week. This was the second biggest single-day fall. But Infibeam witnessed such sharp falls earlier.
More|
| |
APOLLO HOSPITALS SHARE PRICE
Oct 15, 2018 (Close)
TRACK APOLLO HOSPITALS
- Track your investment in APOLLO HOSPITALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON APOLLO HOSPITALS
APOLLO HOSPITALS - INDRAPRASTHA MEDICAL COMPARISON
COMPARE APOLLO HOSPITALS WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.